mRNA 3745
Alternative Names: mRNA-3745Latest Information Update: 31 Dec 2025
At a glance
- Originator Moderna Therapeutics
- Class RNA
- Mechanism of Action Glucose 6 phosphatase expression stimulants
-
Orphan Drug Status
Yes - Glycogen storage disease type I
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Glycogen storage disease type I
Most Recent Events
- 20 Nov 2025 Discontinued - Phase-I/II for Glycogen storage disease type I (In adolescents, In children, In the elderly, In adults) in Canada (IV) due to strategic prioritization
- 20 Nov 2025 Discontinued - Phase-I/II for Glycogen storage disease type I (In adolescents, In children, In the elderly, In adults) in USA (IV) due to strategic prioritization
- 28 Feb 2024 mRNA 3745 receives Orphan Drug status for Glycogen storage disease type I in European Union prior to February 2024